Navigation Links
Mindray Medical Provides Mid-Year Update on Product Development
Date:7/19/2010

SHENZHEN, China, July 19 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for the first half of 2010.

In the first half of the year, the company successfully released a total of four products across its three product lines. These include: a lower-end surgical bed, an additional advanced biochemistry analyzer; a feature-enhanced hand-carried color ultrasound system; and a new digital radiography system model. Full product descriptions are provided below.

"We are excited about the progress we have made with the addition of these four new products," commented Mr. Li Xiting, Mindray's president and co-chief executive officer. "Mindray continues to be aggressive in bringing its high-quality, competitively-priced products to market. A strong R&D initiative is an integral part of Mindray's strategy to maintain competitive advantage and generate additional revenue from new market opportunities. We are pleased with the current development of our product lines and are well-positioned to meet our goal of launching an additional seven to nine products in 2010."

    Products

    Patient Monitoring and Life Support
    -- HyBase 1000 - is a lower-end surgical bed that provides maximum comfort
       and great convenience to end-users, can suit various surgical
       disciplines, and offers a full-safety guarantee.

    In-Vitro Diagnostic Products
    -- BS-800 - is the newest high-level instrument from Mindray. This model
       not only provides superior performance and reliability, but is also
       innovative in structure, function, and application.

    Medical Imaging System
    -- M-7 - is an upgraded hand-carried color ultrasound system which
       received both the CE mark and FDA approval. A winner of the prestigious
       2010 Reddot design award, M7 is a productivity power station designed
       to meet current and future customer needs. With its sharp and clear
       image quality, M-7 can be used for diagnoses across a broad spectrum,
       including the abdominal, vascular and cardiac specialties. M7 enables
       clinicians to achieve an enhanced level of diagnostic confidence and
       efficiency.

    -- DigiEye 760 - is the second model in Mindray's Digital Radiographic
       System and mainly consists of an FPD (flat-panel detector), X-ray
       generator, X-ray tube, mobile patient table, ceiling suspension and
       integrated workstation with the most advanced and innovative software
       technologies.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global operational headquarters in Shenzhen, China, and multiple sales offices in major domestic and international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .

    For investor and media inquiries please contact:

    In the U.S.:

     John Capodanno
     FD
     Tel:   +1-212-850-5705
     Email: john.capodanno@fd.com

     Bryan Armstrong
     FD
     Tel:   +1-312-553-6707
     Email: bryan.armstrong@fd.com

    In China:

     May Li
     Mindray Investor Relations
     Tel:   +86-755-2658-2518
     Email: ir@mindray.com


'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray Medical to Present at J.P. Morgan China Conference 2010
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Globus Medical Raises $110 Million in Series E Financing Round
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Boston University Biomedical Engineers Find Chink in Bacterias Armor
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... 19, 2017 Global Surgical Drainage Device Market: ... used to remove excess liquid and air. The fluid ... bile or lymph. Surgical drains are used in a ... orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. Common ... prevent accumulation of fluid e.g. blood or pus. Surgical ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
(Date:4/24/2017)... ... ... As part of the nationwide Days of Remembrance effort led by the ... Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced that it ... Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip to Germany ...
(Date:4/24/2017)... ... ... The bar for just about everything—apparel, eyewear, cars and even phone cases—is ... and film stardom.(1) Not to be left out is that most desired of commodities, ... gamut from being encrusted with jewels and precious metals to, at the very least, ...
(Date:4/24/2017)... ... April 24, 2017 , ... The California Dental Association Foundation’s two-day volunteer dental ... 1,961 people during the April 22-23 event at the San Mateo Event Center. ... barriers to care, CDA Cares educates the public and policymakers about the importance of ...
(Date:4/24/2017)... ... April 24, 2017 , ... Veteran Theresa James awoke to the ... life forever. , In “Healing Tears,” James depicts every parent’s worst nightmare, when her ... I began journaling conversations and situations throughout my divorce,” James said. “After the death ...
Breaking Medicine News(10 mins):